Trials

ADELE trial open to recruitment

ANZGOG's ADELE study is a randomised phase 2 trial that aims to improve outcomes for women with high-risk endometrial cancer. Led by Principal Investigator Prof Linda Mileshkin & co-chair Dr Yeh Chen Lee, the [...]

ADELE trial open to recruitment2023-06-26T17:05:52+10:00

ANZGOG celebrates International Women’s Day with Prof Anna deFazio and Assoc Prof Caroline Ford

To mark International Women’s Day, ANZGOG celebrates the women leading gynaecological cancer research in a Q&A with Professor Anna deFazio and Associate Professor Caroline Ford Professor Linda Mileshkin and Associate Professor Caroline Ford [...]

ANZGOG celebrates International Women’s Day with Prof Anna deFazio and Assoc Prof Caroline Ford2022-03-09T03:42:39+11:00

Guidelines for cellular and molecular pathology content in clinical trial protocols published

The SPIRIT-Path guidelines for the inclusion of pathology in clinical trial protocols have been published in The Lancet Oncology. Prof Anna DeFazio, Chair TR-ANZGOG Steering Committee The SPIRIT-Path extension guidelines were developed [...]

Guidelines for cellular and molecular pathology content in clinical trial protocols published2021-10-07T05:58:12+11:00

Exploring aspirin as an ovarian cancer preventative for women with BRCA 1/2 mutations

STICs and STONEs is a randomised, Phase II, double-blind, placebo-controlled trial of aspirin in the prevention of ovarian cancer in women with BRCA1 and BRCA2 mutations. Prof Phillips, Principal Investigator of STICs and STONEs, [...]

Exploring aspirin as an ovarian cancer preventative for women with BRCA 1/2 mutations2021-09-28T03:53:44+10:00
Go to Top